Conference Coverage
Conference Coverage
Early infection-related hospitalization portends poor breast cancer prognosis
Particularly close monitoring for adverse breast cancer outcomes is warranted for women with an infection-related hospitalization during the first...
Conference Coverage
VIDEO: Patient-reported outcomes differ by age with anastrozole versus tamoxifen for DCIS
Conference Coverage
VIDEO: Is anastrozole or tamoxifen best for secondary prevention of DCIS?
Conference Coverage
VIDEO: Beta-blocker prevented trastuzumab-related drop in LVEF
Conference Coverage
HU noninferior to transfusion for stroke prevention in SCD
Photo courtesy of ASH ORLANDO, FL—Hydroxyurea (HU) is noninferior to chronic blood transfusions for reducing the risk of stroke in children with...
Conference Coverage
Combination offers ‘important new option’ for CLL, team says
Photo courtesy of ASH ORLANDO, FL—Idelalisib, the first-in-class PI3Kδ inhibitor, combined with bendamustine and rituximab (BR) for relapsed/...
Conference Coverage
Group recommends adding rituximab to ALL therapy
Photo courtesy of ASH ORLANDO, FL—Investigators from the Group for Research on Adult Lymphoblastic Leukemia (GRAALL) recommend integrating...
Conference Coverage
VIDEO: Estrogen receptor gene mutations linked to poorer survival
Conference Coverage
EADV: Fresh insights into Gorlin syndrome
Gorlin syndrome imposes an impressively heavy burden on affected patients.
Conference Coverage
Triplet disappoints in follicular lymphoma trial
Photo courtesy of ASH ORLANDO, FL—A 3-drug regimen is likely not worth pursuing as a first-line treatment option for follicular lymphoma (FL),...
Conference Coverage
Rivaroxaban performs as expected in clinical practice
ORLANDO, FL—“Real-world” data appear to confirm phase 3 results with rivaroxaban in patients who have deep vein thrombosis (DVT), with or without...